Evaluation of Efficacy and Safety of SDN-037

NCT03426267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation and Pain Associated With Ocular Surgery

Interventions

DRUG: SDN-037
DRUG: Placebo

Sponsor

Sun Pharma Advanced Research Company Limited